Given the role of DDB2 in DNA repair, its deletion increases the sensitivity of breast cancer, HNSCC, and other cancer cells to genotoxic therapies such as PARPi (ADP-ribose polymerase inhibitors), the chemotherapeutic drug cisplatin, and radiotherapy [93]. The gene discussed is DDB2; the disease is cancer.